Innovation

Single Molecule Epigenetic Analysis in Nanofluidic Channels

Cornell University
posted on 03/07/2010

Single Molecule Epigenetic Analysis in Nanofluidic Channels


Innovation Details
 

Detailed Description

A new method and device for identifying epigenetic modifications to chromosomes.  While it has been realized that epigenetic modifications have profound effects on cell development and disease conditions, current methods used to obtain epigenetic information are slow, require genetic material from many thousands of cells, and query only one epigenetic modification at a time.  The novel Cornell method involves a unique nanofluidic device that will allow information about multiple epigenetic marks to be obtained simultaneously and more rapidly from small samples, using a single-molecule analytical method.  The device isolates individual molecules of DNA or chromatin and optically identifies labels indicating the existence of a specific epigenetic state. A multiplexed format will further permit searching for the existence of many epigenetic conditions, simultaneously, in a single sample.

 

 

Potential Applications

  • Epigenetic research, particularly epigenomic profiling and mapping

 

 

Advantages

  • Multiple mark information obtained simultaneously
  • Rapid analysis of very small samples
  • Multiplexed format

 

File Number: 4823 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact the case manager at Cornell University for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...